BRPI0410911A - mutantes acapsulares de p. multocida por deleção de hyae - Google Patents

mutantes acapsulares de p. multocida por deleção de hyae

Info

Publication number
BRPI0410911A
BRPI0410911A BRPI0410911-2A BRPI0410911A BRPI0410911A BR PI0410911 A BRPI0410911 A BR PI0410911A BR PI0410911 A BRPI0410911 A BR PI0410911A BR PI0410911 A BRPI0410911 A BR PI0410911A
Authority
BR
Brazil
Prior art keywords
multocida
acapsular
hyae
hyae deletion
birds
Prior art date
Application number
BRPI0410911-2A
Other languages
English (en)
Inventor
Robert E Briggs
Fred M Tatum
Original Assignee
Biotechnology Res & Dev
Us Agriculture
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotechnology Res & Dev, Us Agriculture filed Critical Biotechnology Res & Dev
Publication of BRPI0410911A publication Critical patent/BRPI0410911A/pt
Publication of BRPI0410911B1 publication Critical patent/BRPI0410911B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/102Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)

Abstract

"MUTANTES ACAPSULARES DE P. MULTOCIDA POR DELEçãO DE HYAE". Mutantes acapsulares de P. multocida por deleção de hyaE podem ser administrados a mamíferos, especialmente a ungulados, ou a aves, para proporcionar imunidade protetora contra P. multocida do tipo nativo, para impedir ou reduzir a gravidade de septicemia hemorrágica ou de pneumonia em mamíferos, por exemplo, especialmente em gado, ungulados e em animais de estimação, ou de cólera aviário em aves, especialmente em aves domésticas.
BRPI0410911-2A 2003-07-02 2004-07-02 Mutantes acapsulares de p. multocida por deleção de hyae BRPI0410911B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60893103P 2003-07-02 2003-07-02
US60/608,931 2003-07-02
PCT/US2004/021274 WO2005003330A2 (en) 2003-07-02 2004-07-02 Acapsular p. multocida hyae deletion mutants

Publications (2)

Publication Number Publication Date
BRPI0410911A true BRPI0410911A (pt) 2006-06-27
BRPI0410911B1 BRPI0410911B1 (pt) 2014-07-08

Family

ID=33564219

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410911-2A BRPI0410911B1 (pt) 2003-07-02 2004-07-02 Mutantes acapsulares de p. multocida por deleção de hyae

Country Status (20)

Country Link
US (1) US7351416B2 (pt)
EP (1) EP1638598B1 (pt)
JP (2) JP5001647B2 (pt)
KR (1) KR101119216B1 (pt)
CN (1) CN1798574B (pt)
AT (1) ATE347373T1 (pt)
AU (1) AU2004254619B2 (pt)
BR (1) BRPI0410911B1 (pt)
CA (1) CA2530779C (pt)
DE (1) DE602004003582T2 (pt)
DK (1) DK1638598T3 (pt)
ES (1) ES2278344T3 (pt)
HK (1) HK1088561A1 (pt)
HR (1) HRP20070084T3 (pt)
NZ (1) NZ543771A (pt)
PL (1) PL1638598T3 (pt)
PT (1) PT1638598E (pt)
SI (1) SI1638598T1 (pt)
WO (1) WO2005003330A2 (pt)
ZA (1) ZA200509533B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080241192A1 (en) * 2007-03-26 2008-10-02 Wyeth Vaccination against multiple serotypes of pasteurella multocida
JP5808671B2 (ja) * 2008-11-10 2015-11-10 ノヴォ ノルディスク アー/エス 機能グループii莢膜遺伝子クラスターを有しないe.colibl21株
US9115547B2 (en) * 2009-06-22 2015-08-25 Frank's International, Llc Large diameter tubular lifting apparatuses and methods
WO2010149190A1 (en) 2009-06-26 2010-12-29 Max-Planck-Gesellschaft Zur Novel fluorinated rhodamines as photostable fluorescent dyes for labelling and imaging techniques
US9314519B2 (en) 2012-08-21 2016-04-19 Intervet Inc. Liquid stable virus vaccines
EP3384927B1 (en) 2012-11-08 2022-07-06 Boehringer Ingelheim Animal Health USA Inc. Attenuated manheimia haemolytica vaccines and methods of making and use
US20140147475A1 (en) 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
US9393298B2 (en) 2013-03-15 2016-07-19 Intervet Inc. Liquid stable bovine virus vaccines
US9480739B2 (en) 2013-03-15 2016-11-01 Intervet Inc. Bovine virus vaccines that are liquid stable
AU2014234452B2 (en) 2013-03-18 2018-02-22 Intervet International B.V. Vaccine to protect a ruminant against pneumonia caused by Mannheimia haemolytica
AR097762A1 (es) 2013-09-27 2016-04-13 Intervet Int Bv Formulaciones secas de vacunas que son estables a temperatura ambiente
ES2824402T3 (es) 2013-11-01 2021-05-12 Boehringer Ingelheim Animal Health Usa Inc Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
AR099470A1 (es) 2014-02-17 2016-07-27 Intervet Int Bv Vacunas de virus de aves de corral líquidas
TWI670085B (zh) 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
EP3188750B1 (en) 2014-09-03 2020-03-11 Intervet International B.V. Attenuated bovine coronavirus and related vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US6086894A (en) * 1996-06-27 2000-07-11 Virginia Tech Intellectual Properties, Inc. Recombinant vaccine for diseases caused by encapsulated organisms
US20010018055A1 (en) * 1997-09-25 2001-08-30 Briggs Robert E. Deletion mutants of virulence factors of pasteurellaceae
IL158007A0 (en) * 2001-03-23 2004-03-28 S2 Technologies Inc Development and testing system and method
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7449178B2 (en) * 2002-04-05 2008-11-11 Merial Limited Attenuated gram negative bacteria
ES2346915T3 (es) * 2002-04-05 2010-10-21 Merial Bacterias gram negativas atenuadas.

Also Published As

Publication number Publication date
DK1638598T3 (da) 2007-03-26
KR101119216B1 (ko) 2013-03-18
ATE347373T1 (de) 2006-12-15
US7351416B2 (en) 2008-04-01
JP2011024587A (ja) 2011-02-10
HK1088561A1 (en) 2006-12-08
CA2530779A1 (en) 2005-01-13
CA2530779C (en) 2012-06-05
CN1798574B (zh) 2013-12-11
DE602004003582T2 (de) 2007-09-20
US20050106185A1 (en) 2005-05-19
KR20060020657A (ko) 2006-03-06
DE602004003582D1 (de) 2007-01-18
WO2005003330A3 (en) 2005-03-03
AU2004254619B2 (en) 2009-05-21
AU2004254619A1 (en) 2005-01-13
PL1638598T3 (pl) 2007-05-31
WO2005003330A2 (en) 2005-01-13
ES2278344T3 (es) 2007-08-01
NZ543771A (en) 2008-05-30
SI1638598T1 (sl) 2007-04-30
PT1638598E (pt) 2007-03-30
JP5649881B2 (ja) 2015-01-07
JP5001647B2 (ja) 2012-08-15
EP1638598A2 (en) 2006-03-29
BRPI0410911B1 (pt) 2014-07-08
HRP20070084T3 (en) 2008-09-30
CN1798574A (zh) 2006-07-05
JP2007524398A (ja) 2007-08-30
EP1638598B1 (en) 2006-12-06
ZA200509533B (en) 2007-03-28

Similar Documents

Publication Publication Date Title
HK1088561A1 (en) Acapsular i p. multocida hyae /I. deletion mutants
AR076613A1 (es) Alimento para mascotas en forma de alimento granulado recubierto
NO971051D0 (no) Middel for å öke produksjonen av oppdretts- og produksjonsdyr i fjærfeindustrien
GT200100210A (es) Agonistas del receptor b3-adrenergico y usos de los mismos.
BRPI0510930A (pt) vacinas de subunidade de prrsv
Murphy et al. Pig‐shed air polluted by α‐haemolytic cocci and ammonia causes subclinical disease and production losses
NO20040354L (no) Fremgangsmater og sammensetninger for kontroll av koksidose
Torre et al. Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice
ATE440502T1 (de) Zusaetze fuer krustentier- bzw. fischfuttermittel sowie futtermittel
FI20021518A0 (fi) Avidiinin lämpökestävyyden lisääminen
WO2003096799A3 (en) Multiple closed nucleus breeding for swine production
BRPI0506699A (pt) método para lavar aves domésticas durante o processamento com composições de ácido peroxicarboxìlicos de cadeias médias
RU2009101018A (ru) Индукция толерантности к белкам яиц
Yap et al. Autophagic elimination of intracellular parasites: convergent induction by IFN-gamma and CD40 ligation?
ATE377943T1 (de) Verfahren zur züchtung von nicht-menschliche säugertieren
Gray et al. Interferon‐γ and nitric oxide production are not required for the immune‐mediated clearance of Brugia malayi microfilariae in mice
BR0115310A (pt) Ração
HUP0200359A2 (en) Articles to be chewed by animals
EA200000305A1 (ru) 8а-АЗАЛИДЫ КАК АНТИМИКРОБНЫЕ АГЕНТЫ В ВЕТЕРИНАРИИ
MXPA05009489A (es) Procedimientos para identificacion de atributos geneticos en animales.
BR0308654A (pt) Compostos imunossupressores, métodos e usos relacionados a eles
ATE419393T1 (de) Polymorphismus des igf2-gens und verbesserte produktionseigenschaften von rindern
EP2097539A4 (en) POLYMORPHISMS IN THE UROCORTIN-3 GENE AND THEIR ASSOCIATION WITH MARBROWING AND SUBCUTANEOUS FAT DEPTH IN BOVINE ANIMALS
CN107347676A (zh) 一种创新型木质狗窝
CN204426256U (zh) 可便于排泄物回收的圈养结构

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 08/07/2014, OBSERVADAS AS CONDICOES LEGAIS.